W1171: Germ Cell and Embryo Development and Manipulation for the Improvement of Livestock
- Duration:
- October 01, 2004 to September 30, 2009
- Administrative Advisor(s):
-
Milan Shipka
(ALK)
- NIFA Reps:
-
Mark Mirando
Adele M Turzillo
Statement of Issue(s) and Justification:
STATEMENT OF THE ISSUE: The knowledge base for understanding the fundamental underlying biological mechanisms and principles of techniques used to enhance germ cell and embryo development and to produce genetically enhanced livestock is limited. Furthermore, the vast majority of these methodologies are extremely inefficient. The efficiencies of these technologies will have to be substantially improved if we are to benefit from the advantages of germ cell and embryo manipulation that can lead to increased food and fiber production. These advantages include the production of more desirable products, new products, value-added products, and increased efficiency of the utilization of natural resources.JUSTIFICATION: The development of transgenic animals used for food and fiber production has significant potential for consumers, animal producers, their communities, and our environment. Potential examples of such transgenic animals are those producing a milk containing human proteins to make a more desirable human baby formula, those producing a leaner, more desirable meat, or those more efficient in growth, reproduction, wool production, or milk production, including those with increased disease resistance (Wall, 2002; Wheeler et al., 2003). Increased efficiencies in production of animal products can be of economic benefit to both consumers and producers and have obvious advantages to the environment in terms of reduced use of natural resources.
Current procedures for the production of experimental transgenic animals can involve the use of in vitro oocyte maturation, in vitro fertilization, in vitro culture, cell culture and nuclear transfer either before or after gene transfer (Hasler et al., 1995, Wall, 2002). This is more practical than recovery of in vivo fertilized embryos, but is still extremely time and labor-consuming. Currently, more than 10 hours of labor are required to produce a single bovine embryo via nuclear transfer for transfer back to a recipient female. When this is coupled with a 1-5% pregnancy rate, an estimated 1000 hours are required to produce a single transgenic offspring. Before transgenic animals can contribute significantly to production systems, their production will have to be far more efficient. The inefficiencies occur during oocyte maturation, during nuclear transfer, during embryo culture and during establishment of pregnancy. Short and long-term storage of the transgenic embryos is necessary for efficient production of transgenic animals, but this technology needs improvement as well (Hurtt et al., 1999).
The details of meiotic maturation of oocytes (particularly the details of nuclear maturation) are beginning to be understood. Much of this work has been done with mouse oocytes; yet differences are known to exist between murine oocytes and bovine, porcine, or ovine oocytes (Cran and Moor, 1989). This is just one of the areas where the proposed multi-state research will contribute to animal production.
Although there have been recent advances in nuclear transfer technology in livestock and laboratory species (Wilmut et al., 1997; Schnieke et al., 1997; Wakayama et al., 1998; Eyestone and Campbell, 1999; Kuhholzer and Prather, 2000; Wheeler and Walters, 2001; Escriba et al., 2002; Niemann et al., 2003; Wang and Zhou, 2003; Mullins et al., 2004), much still needs to be learned regarding the biology and application of these methods to production of transgenic animals. This technology is very inefficient at present (Wilmut et al., 1997; Campbell, 1999; Niemann and Hues, 2000; Niemann and Rath, 2001; Paterson et al., 2003) and needs improvement before it can be widely used for livestock systems. Research to increase the practicality of making transgenic animals is directly in line with FAIR95 Goal 2 "Meet consumer needs in domestic and international markets for competitive and high-quality products from animals. Objective l. Increase efficiencies of production livestock. Objective 2. Enhance the quality of products from animals" (Anonymous, 1993). The economic significance of transgenic animals to U.S. animal agriculture in the future cannot be estimated with any confidence. However, the livestock and dairy industries generated over 68 billion dollars of on-farm receipts in 1992 (Anonymous, 1994). Even small effects on efficiency would repay research costs several times over.
A multi-state research approach is an extremely advantageous means to approach these problems efficiently. Alternative approaches can be tested in multiple laboratories, and the effective procedures further tested in the remaining laboratories. Oocyte and embryo procedures appear particularly laboratory dependent; for example, the optimal exposure time for vitrification of mouse oocytes and mouse blastocysts varied significantly among laboratories (Wood et al., 1993; Valdez et al., 1993; Zhu et al., 1993; Shaw et al., 1992). Improvements in nuclear transfer methods and the development of embryonic/ somatic cell lines to serve as nuclei donors are other areas that would benefit from this multiple laboratory approach.
The use of gene transfer alone or in combination with nuclear transfer is very useful for obtaining a variety of information. Some examples are insight into the cell cycle, nuclear and cytoplasmic programming or re-programming, genomic imprinting, gene expression, epigenetics and developmental processes to name just a few. This information can be used in studies to examine basic biological questions, biomedical questions, genetic questions and evolutionary questions as well as applications for agriculture.
This proposal will evaluate two areas critically important to the future success of animal biotechnology: 1) the understanding of the developmental biology and underlying biological mechanisms of fertilization and embryonic development and 2) the refinement of methods for production of genetically modified animals to improve livestock production efficiency.
Related, Current, and Previous Work:
RELATED REGIONAL PROJECTS: Related regional research projects are NC-210 Mapping the Pig Genome, NCR-057 Reproductive Physiology, NEC-80 Biotechnology-Animal Development, and NC1006 Methods to Increase Reproductive Efficiency in Cattle. However, the work is complementary, rather than duplicative. It is assumed that any new multistate projects that may be duplicative of the proposed multistate project will not be approved.The remaining description of current and previous work will be organized by objectives and references are typically to current reviews.
1). Understanding the developmental biology and underlying biological mechanisms of fertilization and embryonic development.
Oocyte Maturation: Use of in vitro matured oocytes in combination with in vitro fertilization for the production of livestock embryos in the laboratory is rapidly increasing (Yang et al., 1998; Telfer et al., 2000; Nagai, 2001; Coy and Romar, 2002; Tosti et al., 2002; Miyano, 2003; Zeuner et al., 2003). These techniques have not only tremendous research value in studying the basic biological events that occur during oocyte maturation, fertilization and early embryonic development, but also provide an inexpensive and readily procurable source of preimplantation livestock embryos. Successful maturation, fertilization and subsequent embryonic development depend heavily on initial oocyte quality. Procedures that could accurately determine an oocytes viability and its likelihood to fertilize and develop as an embryo following in vitro maturation would dramatically improve the efficiency of in vitro embryo production. Alternatively, reliable methods for assessment of viability of in vivo- or in vitro-derived embryos would permit screening of embryos prior to manipulation or transfer procedures. Linking these indicators of embryo viability and successful development with the expression and function of specific genes could also afford valuable insights into mechanisms contributing to embryonic mortality.
An integral aspect of in vitro embryo production is successful oocyte maturation. Oocyte maturation is dependent on two separate events: nuclear maturation and cytoplasmic maturation (Fulka et al., 1998). Nuclear maturation refers to the progression of the oocyte from the dictyate stage of meiosis I to metaphase II and extrusion of the first polar body. The process of cytoplasmic maturation appears to be the critical factor that determines the success of producing viable embryos. Determining and quantifying the indicators of cytoplasmic maturation in the oocyte would enable more efficient selection of oocytes for fertilization and embryo development in vitro.
Involvement of cyclin and p34cdc2 kinase in nuclear maturation has been convincingly demonstrated in a number of species (Cran and Moor, 1989, Polanski et al., 1998). Other details of nuclear maturation are yet to be understood and exhibit some species variation.
The biology of cytoplasmic maturation is even less well understood (Krisher and Bavister, 1998; Bevers and Izadyar, 2002; Lindsey et al., 2002; Krischek and Meinecke, 2002; Armstrong et al., 2003). The anatomy of the oocyte changes, including the development of microtubule organizing centers and the migration of intracellular organelles (Mattson and Albertini, 1990). The ability of the oocyte plasma membrane to fuse with sperm increases with increasing maturity, at least in the hamster (Zuccotti et al., 1991).
There appears to be a lack of synchrony between nuclear and cytoplasmic maturation in vitro. Porcine oocytes may achieve nuclear maturation to metaphase II after as few as 24 hours of culture, but do not possess developmental competence until over 40 hours of maturation (Grupen et al., 1997). It is possible to prevent spontaneous nuclear maturation by the addition of dibutyryl cAMP (Nekola and Smith, 1975) or roscovitine ((Franz et al., 2003) to the maturation medium, thus allowing more time for cytoplasmic maturation while avoiding nuclear aging. Developmental competence might be improved further by delaying nuclear maturation for a longer period of time because oocyte maturation in vivo requires several days as compared with the 42 to 44 hour maturation period typically reported for porcine oocytes.
Studies have indicated that morphological characteristics such as appearance of cumulus cells, oocyte size, and the time of polar body extrusion are related to the ability of oocytes to fertilize and develop into viable embryos (Younis al., 1989; Dominko and First, 1992). There are distinct morphological differences between in vivo and in vitro matured porcine oocytes (Wang et al., 1998). The slow or incomplete cortical granule release following sperm penetration (Wang et al., 1997) and uneven distribution of cortical granules within the oocyte (Wang et al., 1998) might be related to the high incidence of polyspermy reported for porcine oocytes matured and fertilized in vitro. Overall, the limited developmental competence of porcine oocytes matured in vitro appears to be related to failure of adequate cytoplasmic rather than nuclear maturation (Nagashima et al., 1996).
Equine oocytes require a longer in vitro maturation period than bovine oocytes (Shabpareh et al., 1993). Preovulatory follicular fluid before the LH surge inhibits maturation, while by 20 hours after the LH surge, follicular fluid stimulates oocyte maturation, even in the presence of inhibitory factors (Romero and Seidel, 1994). Prochazka et al. (2000) found that medium supplemented with either EGF or FSH could equally support nuclear maturation and cumulus expansion of porcine oocytes isolated from follicles 6 to 7 mm in diameter.
Fertilization and Sperm Capacitation: Fertilization and initial cleavage occur in the mammalian oviduct. Although in vitro production and development of farm animal embryos have become routine, their development in vitro remains far below in vivo embryos. The secretion of several factor(s) from the mammalian oviduct may contribute to the superior development of in vivo produced embryos. A high molecular weight oviductal glycoprotein (OGP) is synthesized and secreted by the secretory cells of the oviduct. The presence of OGP is highest during the periovulatory period and declines thereafter, suggesting its potential role during in vivo fertilization and possibly during the initial cleavage stages (Malette et al., 1995; Verhage et al., 1998).
As part of the cytoplasmic maturation of oocytes, the protein composition of the oocyte plasma membrane changes including an increased ability to bind and/or fuse with sperm (Zuccotti et al, 1994; Cohen et al., 1996). Oocyte receptors for the sperm plasma membrane are either described/ hypothesized as the complementary receptors for putative ligands or in one case as integrin heterodimers. Wheeler et al. (1996) have verified that bovine oocytes increase their ability to bind sperm plasma membrane during the 22 hours of in vitro maturation and that this increase is dependent upon protein synthesis. Recently, a putative oocyte plasma membrane protein (POMP) receptor for sperm was identified (Berger et al., 1998; 1999; Yen and Berger, 1999).
Sperm gain the ability to bind and fuse with the oocyte plasma membrane in the equatorial segment during capacitation. Modification of one or more of the ligands or exposure of one or more of the ligands for the oocyte plasma membrane would appear to be an essential component of capacitation. A number of potential sperm ligands has been proposed to interact with the oocyte in different species; species specificity (at least among mammalian orders) would be expected. Ash et al. (1995) identified four predominant binders of the oocyte plasma membrane as potential porcine sperm ligands for the porcine oocyte plasma membrane.
Assisted Fertilization: It has been shown that capacitation status of bovine sperm for intracytoplasmic sperm injection (ICSI) is irrelevant, and that there is a benefit of activation of oocytes with the calcium ionophore A23187 (Chen and Seidel, 1997). Further, a beneficial effect by activating equine oocytes with ICSI has been shown (Kato et al., 1997). A novel method of increasing fertilization rates in vivo via a sperm-oocyte adhesive peptide (Amann et al., 1999) may also be promising in vitro.
Sex Determination: The ability to pre-select the sex of offspring would have tremendous economic benefit to beef and dairy producers alike. One approach has been to attempt to physically separate X- from Y-chromosome bearing spermatozoa using modified flow cytometry (Johnson et al., 1994). However, this procedure does not have widespread application at the present time, due to the cost of the equipment and limitations on sorting rate (Seidel and Garner, 2002).
It may be possible to significantly alter the sex ratio by screening and then selecting, ejaculates with a naturally altered ratio of X- to Y-bearing spermatozoa. Chandler et al. (1998) reported that within sires the ratio of X- to Y-bearing spermatozoa from different ejaculates of semen can be skewed significantly toward one sex, and this skewed ratio appears to translate into altered sex ratio of offspring. The ratio of X- to Y-chromosome bearing spermatozoa of ejaculates within bulls was found to be significantly skewed (~84%) in about 20% of the ejaculates evaluated. However, there is considerable controversy surrounding these findings. Studies are needed to confirm that the ratio of X- to Y bearing spermatozoa is skewed in some ejaculates of semen.
Embryo Development: Although the methodology for maintaining mammalian livestock embryos in culture has existed for many years, the ability of the present systems to support normal development is limited. This is especially true of early embryos that often exhibit developmental blocks in vitro (Krisher and Bavister, 1998). These blocks are thought to be the result of inadequate culture systems since similar blocks are not found in vivo. In addition, numerous studies have shown that there is a decline in embryo viability corresponding to the length of time they are held in culture (Davis, 1985). More recently, co-culture systems have been developed to at least partially overcome the deficiencies associated with earlier systems (Trounson et al., 1994). The benefits of co-culture systems in promoting in vitro development are well established, but the mechanisms by which these benefits are achieved have yet to be elucidated. Evidence is accumulating that growth factors have an autocrine and paracrine role in embryo development (Gandolfi, 1994; Heyner et al., 1994, Glover and Seidel, 2003). Tremendous effort will be required to define these effects, but secretion of growth factors by the co-cultured cells may be at least one of the mechanisms for the beneficial effect of co-culture (Winger et al., 1997).
Experiments have confirmed the detrimental effects of high oxygen and beneficial effects of certain antioxidants on in vitro development of bovine embryos (Caamaqo et al., 1996, 1998; Olson and Seidel, 2000). Optimal ways have been determined to condition media with buffalo rat liver cells for culturing bovine embryos (Funston et al., 1997). Studying gene expression in elongating bovine embryos has shown the IGF system to have important regulatory roles (Keller et al., 1998). One of our stations (Colorado) has identified several genes with increased expression as embryos elongate (Glover and Seidel, 2003).
Extracellular matrix (ECM)-degrading proteinases are believed to play pivotal roles in early embryo development and embryo-uterine interactions (Cross et al., 1994). ECM-degrading proteinases include the plasminogen activator (PA)-plasmin system and the family of matrix metalloproteinases (MMP) (Vassalli and Pepper, 1994). The laboratory of one of our contributing stations (Oregon) has demonstrated that endodermal cells express PA during migration in vitro in sheep and cattle. During the periods of endodermal cell migration and trophoblastic expansion and elongation, ovine embryos express PA, MMP-9 and three MMP inhibitors (TIMPs-1, -2 and -3).
Blastocyst production by in vitro methods has plateaued at around 40% despite various attempts to improve culture conditions. The 40% development rate falls short of the 85 to 95% that occurs in vivo. Various attempts have been made by using co-culture systems, semi-defined mediua, or chemically defined media in a variety of culture conditions; however, in vitro production of blastocysts still hovers at or below 40% (Thibodeaux et al., 1992; Choi et al., 1998; Krisher and Bavister, 1998). Furthermore, in vitro-produced blastocysts are usually developmentally retarded with fewer inner cell mass cells compared with embryos developed in vivo. The apparent lack of biologic culture conditions necessitates further innovation in tissue culture methodology and the pursuance of further research in this area.
Epigenetic refers to changes in gene expression that occur without a change in DNA sequence. Two key factors are associated with the epigenetic control of gene expression 1) DNA methylation and 2) histone modifications which include methylation, phosphorylation and acetylation (Bird and Wolffe, 1999; Jenuwein and Allis, 2001). Shortly after fertilization, mammalian embryos undergo genome-wide epigenetic reprogramming by demethylation during preimplantation development followed later by de novo remethylation (Monk et al., 1987; Dean et al., 2001). This epigenetic reprogramming is essential for normal development to proceed. Aberrant reprogramming has been clearly linked to failed embryonic development. (Dean et al., 2001; Howlett and Reik, 1991; Shi and Haaf, 2002). Moreover, there is growing body of evidence which, suggests that inadequate epigenetic reprogramming during early mammalian development may result in large offspring syndrome (LOS) and other developmental abnormalities (Young et al., 1998; Hill et al., 2000a; Sinclair et al., 2000). Clearly, understanding the factors and mechanisms which control epigenetic reprogramming during early mammalian development are of critical importance
2). Refinement of methods for production of genetically modified animals to improve livestock production efficiency.
Nuclear Transfer: Nuclear transfer, which involves the transfer of each nucleus from a multicellular embryo into an enucleated metaphase II oocyte, has been developed in several species (Willadsen, 1986; Prather et al., 1987; Stice and Robl, 1988.). Nuclear transfer has become an active field of research over the last decade, culminating in reports of live offspring from differentiated cells of sheep, cattle, and mice (Schnieke et al., 1997; Wells et al., 1997; Cibelli et al., 1998; Kato et al., 1998; Wakayama et al., 1998). Dolly was not a fluke. Dozens of laboratories are producing calves and lambs whose genetic parents are somatic cells, often derived from adults (Cibelli et al., 2002). This technology has three broad applications: 1) applied animal breeding to copy outstanding animals (e.g., proven bulls), 2) a tool for basic research, (e.g., mechanisms of differentiation), and 3) a biotechnological tool (e.g., vastly simpler approaches to making transgenic farm animals).
Although offspring have been produced in livestock using nuclear transplantation, the efficiency rate has been low (Wilmut et al., 1997). In each of the species reported to date, the efficiency is ? 6% (1-6% in sheep, 1-4% in cattle, and 1% in pigs). The factors affecting the efficiency of nuclear transplantation are: enucleation of the recipient oocyte, fusion of the transplanted nucleus to the enucleated oocyte cytosol, activation of the oocyte, and "re-programming" of the transferred nucleus. Activation may be the factor responsible for the greatest loss in efficiency (Collas and Robl, 1990). However, the general consensus is that nuclear transfer efficiency is much too low to be economically viable except in very limited applications. The low efficiency also makes it an expensive research tool. Any increase in efficiency will greatly enhance the value of this technology and will contribute to our understanding of changes that must occur in chromosomes to allow embryonic gene expression patterns. It is also critical to begin to understand how potentially subtle modifications in the nuclear structure impact the ability of a cell to contribute to production of offspring and yet another to fail.
An important aspect of this field, in the past and the future, concerns understanding the abnormalities of offspring produced by nuclear transplantation (Seidel et al., 1997; Garry et al., 1998). Such calves and lambs have high rates of fetal and neonatal death. At birth, they are hypoxic, hypoglycemic, hypothermic, and readily die (Garry et al., 1998). It has been hypothesized that these animals have a genetically or epigenetically abnormal placenta, since the calves themselves appear normal genetically (Garry et al., 1996).
Transgenic Methodologies: The ability to produce novel proteins in the mammary gland of domestic animals will have an important impact on agriculture. With the ability to use genetically enhanced somatic cells as nuclear donors, this objective appears to be attainable at rates which will allow use of domestic animals. Several years ago one of our contributing stations (Colorado) combined transgenics with in vitro-produced bovine embryos (Thomas et al., 1993), and produced the first transgenic calf demonstrated to, in fact, express a transgene (Bowen et al., 1994). Additional previous work has included the production and study of transgenic mice. Targeted milk properties include processing functionality (Maga et al., 1995; Gutierrez-Adan et al. 1996), anti-microbial properties (Maga et al., 1997), and the application of antisense constructs to obtain efficient down-regulation of protein secretion into the milk (Sokol et al., 1998).
Cryopreservation: Cryopreservation of in vivo produced bovine embryos is quite successful and limited success has been achieved with other species such as late-stage porcine embryos (Nagashima et al., 1994; Dobrinsky, 1997). Initially, in vitro matured and fertilized embryos appeared more susceptible to damage during freezing and thawing (Leibo and Loskutoff, 1993, Arav et al., 1996). Alterations in in vitro maturation and culture can affect the susceptibility of the in vitro-produced oocytes to cryo-damage. The large equine embryo (routinely collected non-surgically) is particularly challenging to cryopreserve. Recently, a new concept was developed, step-down equilibration, to cryopreserve such embryos successfully (Young et al., 1997). Recently, equine and bovine oocytes have successfully been vitrified (Hurtt et al., 1999), and matured oocytes survived vitrification better than immature ones.
Stem Cell Biology: Transgenic animals have great potential for livestock production, but the potential is still unrealized. The low efficiency in their production is a primary reason (Ebert and Schindler, 1993; Halter et al., 1994). These inefficiencies occur at all stages. An aspect of great importance in this regard is the isolation and manipulation of undifferentiated, pluripotent embryonic cells. There are two types of pluripotent embryonic cells, embryonic stem (ES) cells and embryonic germ (EG) cells. ES cells are isolated in culture from blastocyst-stage embryos, and EG cells are isolated from cultured primordial germ cell (PGC).
ES cells first were isolated from mouse embryos (Evans and Kaufman, 1981; Martin, 1981) and since have been used as a model for mammalian embryogenesis and more recently for genetic manipulation. Due to their ability to integrate foreign DNA and thereafter differentiate into any and all tissues of a normal individual, ES cells are effective vehicles for genetic engineering and for creating laboratory animal models of human diseases. Despite considerable effort, progress toward isolation of ES cells from agricultural species has been slow. Some of the more promising results have been achieved with pigs (Wheeler, 1994). To date, production of embryonic stem cell lines has been much more difficult in livestock species than in mice (Sims and First, 1994; Rund et al., 1996; Wheeler and Choi, 1997a; Iwasaki et al., 2000; Talbot et al., 2002; Denning and Priddle, 2003; Bonde et al. 2003; Wheeler and Malusky, 2003).
In the early 1990s, several laboratories reported isolation of ES-like cells from cultures of primordial germ cells (PGCs)(Matsui et al., 1992; Resnick et al., 1992). These cells were called EG cells to distinguish them from blastocyst-derived ES cells, but EG and ES cells appear to share many characteristics, including the ability to differentiate into numerous cell types. One of our contributing stations (California) successfully isolated EG cells from porcine PGC (Shim et al., 1997, Shim and Anderson, 1998), the first example in a species other than the mouse. Recent successes with isolation of ES and EG cells from agricultural species have been exciting, but generally these ES and EG cells have a low efficiency of incorporation into normally developing embryos. Moreover, in no instance have livestock ES or EG cells been shown to develop into gametes, a prerequisite to their use in genetic engineering. Several laboratories involved in the W-171 project have a history of productive research with ES and EG cells. By combining the resources, ingenuity and collaborative efforts from these laboratories, this Regional Research Project could yield undifferentiated cell lines of practical value to animal agriculture, a phenomenal contribution to animal agriculture.
Objectives
- Understand the biology and underlying mechanisms of gamete development, fertilization and embryogenesis.
- Refine methods for production of genetically modified animals to improve livestock production efficiency.
